Warning signs in Cuban patients with dengue fever according to new reviewed classification of the World Health Organization

Authors

  • Osmany Enrique Tamayo Escobar Centro de Investigaciones Médico-Quirúrgicas, La Habana
  • Tania María García Olivera Centro de Investigaciones Médico-Quirúrgicas, La Habana
  • Nilia Victoria Escobar Yéndez Hospital General Docente “Dr. Juan Bruno Zayas Alfonso”, Universidad de Ciencias Médicas, Santiago de Cuba
  • Daniel González Rubio Instituto de Medicina Tropical “Pedro Kourí”, La Habana
  • Osvaldo Castro Peraza Instituto de Medicina Tropical “Pedro Kourí”, La Habana

Keywords:

dengue fever, dengue fever without warning signs, dengue fever with warning signs, intravenous hydration, reemerging disease

Abstract

An observational, descriptive and cross sectional study was carried out in "Pedro Kourí" Tropical Medicine Institute from Havana, where 485 patients were admitted from January to December, 2012 with diagnosis of infection due to dengue fever, from whom a sample of 247 was chosen. Among the most common warning signs there were the increasing values of hematocrit (54.6 %), and the intense or sustained abdominal pain or both types (46.1 %). The warning signs generally appeared when fever ceased, and of the total of patients that presented it, 81.2 % at some moment of their clinical course were treated with early intravenous hydration, and none developed the serious form of the disease. The parenteral hydration therapy began belatedly in 18.8 % of the affected, including all those in severe state.

Downloads

Download data is not yet available.

References

1. Alexander N, Balmaseda A, Coelho IC, Dimaano E, Hien TT, Hung NT, et al. Multicentre prospective study on dengue classification in four South-east Asian and three Latin American countries. Trop Med Int Health. 2011;16(8):936-48.
2. World Health Organization. Dengue: guidelines for diagnosis, treatment, prevention and control. Geneva: WHO; 2009.
3. Organización Panamericana de la Salud, Organización Mundial de la Salud. Guías de atención para enfermos de dengue en la región de las Américas. La Paz:OPS/OMS;2010.
4. Kalayanarooj S. Dengue classification: current WHO vs the newly suggested classification for better clinical application? J Med Assoc Thai. 2011;94(3):74-84.
5. Pozo J, Monroy V, Díaz D, Barrios J, Ramos C, Ulloa A, et al. Evaluación de acogida y factores virales asociado con dengue grave en base a la clasificación de la OMS del 2009. RevParásitVect. 2014;7:590-7.
6. Thein TL, Gan VC, Lye DC, Yung CF, Leo YS: Utilities and limitations of the world health organization 2009 warning signs for adult dengue severity. PLoSNeglTropDis. 2013;7:2023-9.
7. Martínez JA. Caracterización clínico-epidemiológica y ecográfica de pacientes con dengue confirmado. Santiago de Cuba. MEDISAN. 2010;14(5):665-74.
8. González D, Castro O, Kourí G, Pérez J, Martínez E, Vazquez S, et al. Classical dengue hemorrhagic fever resulting from two dengue infections spaced 20 years or more apart: Havana, Dengue 3 epidemic, 2001-2002. Internat J InfectDiseas. 2005; 9:280-5.
9. Leo Y, Gan V, Ng E, Hao Y, Ng L, Pok K, et al. Utility of warning signs in guiding admission and predicting severe disease in adult dengue. BMC InfectDis. 2013;13:498-506.
10. Organización Panamericana de la Salud, Organización Mundial de la Salud. Los casos de dengue en las Américas se quintuplicaron en diez años, según nuevos datos de la OPS/OMS. Washington, D.C.: OPS; 2014.
11. Organización Panamericana de la Salud, Organización Mundial de la Salud. Descripción de la situación epidemiológica actual del dengue en las Américas. Washington, D.C.: OPS; 2014.
12. World Health Organization. Dengue, countries or areas at risk, 2013. Geneva: WHO; 2014.
13. Pan American Health Organization,World Health Organization. Number of reported cases of dengue and severe dengue (SD) in the Americas, by country: epidemiological week. Washington, D.C.: PAHO; 2015.
14. Perú. Ministerio de Salud. Incidencia acumulada de dengue sin señales de alarma, con señales de alarma y dengue grave por regiones en el Perú. Lima: MINSA; 2011.
15. Perú. Ministerio de Salud. Resumen de las enfermedades o eventos bajo vigilancia epidemiológica en el Perú. Bol Epidemiol (Lima). 2014;23(22):442-6.
16. YacoubS, Wills B. Predicting outcome from dengue. BMC Med.2014;12:147-9.
17. Simmons C, Farrar JJ, Chau N, Wills B. Dengue: current concepts. N Engl J Med. 2012;366(15):1423-32.
18. Usman HB, Safitri I, Lum L, Martínez E, Kroeger A, Horstick O. Evidence for the use of intravenous rehydration for treating severe dengue with plasma leakage in children and adults: a systematic review. WHO Dengue Bull. 2012;36:149-65.
19. Kularatne SA, Weerakoon KG, MunasingheR,Ralapanawa UK, Pathirage M. Trends of fluid requirement in dengue fever and dengue haemorrhagic fever: a single centre experience in Sri Lanka. BMC Res Notes.2015;8:130-7.
20. Myburgh JA, Mythen MG. Resuscitation fluids. N Engl J Med. 2013;369:1243-51.

Downloads

Published

2018-10-09

How to Cite

1.
Tamayo Escobar OE, García Olivera TM, Escobar Yéndez NV, González Rubio D, Castro Peraza O. Warning signs in Cuban patients with dengue fever according to new reviewed classification of the World Health Organization. MEDISAN [Internet]. 2018 Oct. 9 [cited 2025 Jun. 3];22(8). Available from: https://medisan.sld.cu/index.php/san/article/view/2284

Issue

Vol. 22 No. 8 (2018): MEDISAN

Section

Original Articles

License

All the articles can be downloaded or read for free. The journal does not charge any amount of money to the authors for the reception, edition or the publication of the articles, making the whole process completely free. Medisan has no embargo period and it is published under the license of Creative Commons, International Non Commercial Recognition 4.0, which authorizes the copy, reproduction and the total or partial distribution of the articles in any format or platform, with the conditions of citing the source of information and not to be used for profitable purposes.